JUUL's Major Settlements
JUUL Labs has reached a series of substantial settlements resolving various categories of vaping-related litigation. In 2022, JUUL settled with multiple state attorneys general for approximately $438 million over youth marketing claims. Additional settlements with school districts, individual plaintiffs, and government entities have brought JUUL's total settlement exposure to over $1.7 billion across various proceedings.
These settlements addressed JUUL's aggressive marketing to minors -- using social media influencers, flavored products, and advertising in youth-oriented channels -- that contributed to a dramatic increase in teen nicotine addiction during 2017-2019. The settlements required JUUL to restrict its marketing practices and fund youth anti-vaping programs.
EVALI Lung Injury Claims
The 2019 EVALI outbreak -- which caused severe, sometimes fatal lung injuries in thousands of vapers -- generated personal injury litigation. EVALI was ultimately linked primarily to vitamin E acetate used as a cutting agent in illicit THC vaping cartridges, not to commercial nicotine e-cigarettes. However, some commercial product-related respiratory injury claims also proceeded.
Personal injury claims for EVALI require establishing which specific product caused the injury and whether that product contained the problematic ingredients. Cases involving documented use of illicit THC cartridges have more challenging liability theories against commercial manufacturers. Related: CPAP cancer claims from recalled devices.
Who Qualifies
Minors (or their parents) who became addicted to JUUL or other branded e-cigarette products through youth-targeted marketing may have claims. Individuals who developed serious respiratory conditions attributed to commercially sold vaping products may have personal injury claims. Former smokers sold e-cigarettes as cessation aids who developed nicotine dependence may have consumer fraud claims.
Status 2026
The primary JUUL litigation wave has largely settled. New vaping-related claims -- particularly from newer products and continued youth marketing -- continue to be filed. The vaping regulatory landscape continues to evolve with FDA premarket authorization proceedings.
How to Get Legal Help
If you believe you qualify based on the eligibility criteria described above, the next step is a free consultation with an experienced attorney. Most plaintiff-side attorneys handling these cases work on contingency -- meaning you pay nothing unless your case results in a recovery. Bring any relevant documentation including receipts, correspondence, or evidence of the harm you experienced.
To stay current on case developments, claim deadlines, and settlement news, bookmark this page and subscribe to LawsuitWatch alerts. Coverage is updated as new court filings, settlement announcements, and eligibility changes are made public.
Free Legal Evaluation
Do You Qualify to File a Claim?
Our network of verified plaintiff attorneys offers free, no-obligation case evaluations. Contingency fee representation means you pay nothing unless you win.
Vape Lawsuit: JUUL, Lung Injury & Youth Marketing Claims: Frequently Asked Questions
Answers to the most common questions about this case and your legal options.
Did JUUL settle its lawsuits?
Yes. JUUL has paid over $1.7 billion in various settlements addressing youth marketing, state AG claims, and individual injury claims.
What is EVALI?
EVALI (e-cigarette or vaping product use-associated lung injury) is a serious lung condition linked primarily to vitamin E acetate in illicit THC vaping products during the 2019 outbreak.
Can I sue JUUL for my child's nicotine addiction?
If your minor child became addicted to JUUL through youth-targeted marketing, claims may be available. Consult a consumer protection attorney.
Is there still a JUUL class action?
Many JUUL claims have settled. New claims related to continued practices may still be viable. Check current litigation status with a plaintiff's attorney.
What are the health risks of vaping?
Respiratory effects, nicotine addiction, and in the 2019 EVALI outbreak, severe lung injury. Long-term health effects are still being studied.